NPI: 1417064205 · PRICE, UT 84501 · Rural Acute Care Hospital · NPI assigned 08/25/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 08/25/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,616 | $686K |
| 2019 | 30,910 | $837K |
| 2020 | 27,891 | $897K |
| 2021 | 40,789 | $1.37M |
| 2022 | 41,639 | $1.53M |
| 2023 | 6,982 | $243K |
| 2024 | 5,987 | $436K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 2,290 | 1,352 | $2.26M |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,947 | 2,665 | $572K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 9,865 | 8,489 | $457K |
| 80053 | Comprehensive metabolic panel | 14,329 | 11,748 | $324K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4,045 | 3,673 | $263K |
| 36415 | Collection of venous blood by venipuncture | 3,155 | 2,811 | $236K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 8,054 | 7,282 | $236K |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,001 | 2,624 | $212K |
| J7050 | Infusion, normal saline solution, 250 cc | 3,968 | 3,451 | $169K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,659 | 1,571 | $160K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,686 | 1,553 | $103K |
| 71046 | Radiologic examination, chest; 2 views | 2,466 | 2,294 | $92K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,695 | 3,187 | $86K |
| 81001 | 7,041 | 5,951 | $84K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,532 | 3,158 | $65K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,417 | 3,766 | $43K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,676 | 3,206 | $40K |
| 71045 | Radiologic examination, chest; single view | 1,963 | 1,758 | $31K |
| 87088 | 2,429 | 2,233 | $30K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,092 | 1,841 | $30K |
| 87275 | 819 | 785 | $30K | |
| 87631 | 314 | 295 | $23K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 317 | 293 | $22K |
| 73610 | 205 | 188 | $20K | |
| 86140 | 6,257 | 5,313 | $19K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,539 | 1,272 | $18K |
| 76830 | Ultrasound, transvaginal | 119 | 117 | $17K |
| 87077 | 1,159 | 1,040 | $16K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 499 | 486 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 185 | 184 | $13K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,052 | 661 | $13K |
| 73630 | 271 | 249 | $13K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,558 | 1,435 | $12K |
| 85610 | 1,813 | 1,534 | $12K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 67 | 62 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 585 | 353 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,784 | 2,375 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 328 | 311 | $10K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,979 | 1,557 | $10K |
| 73562 | 156 | 137 | $10K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 38 | 37 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | 3,434 | 3,216 | $8K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 71 | 70 | $8K |
| 84439 | 1,208 | 1,151 | $8K | |
| 73110 | 79 | 67 | $8K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 121 | 104 | $8K |
| 87070 | 200 | 169 | $7K | |
| 80061 | Lipid panel | 978 | 938 | $7K |
| 73030 | 90 | 83 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 15,882 | 12,873 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 239 | 228 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,364 | 3,737 | $6K |
| 73130 | 122 | 102 | $6K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 106 | 97 | $6K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 248 | 247 | $5K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,600 | 1,454 | $5K |
| 86850 | 277 | 246 | $5K | |
| 82962 | 1,017 | 624 | $5K | |
| 84484 | 2,679 | 1,825 | $5K | |
| 74018 | 125 | 119 | $5K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 51 | 50 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,932 | 2,422 | $4K |
| 87420 | 234 | 227 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 810 | 730 | $3K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,220 | 2,034 | $3K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 67 | 64 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 565 | 500 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 225 | 217 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 297 | 277 | $3K |
| 85379 | 1,095 | 1,017 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 118 | 111 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | 820 | 732 | $2K |
| 84702 | 208 | 145 | $2K | |
| 80055 | 26 | 26 | $2K | |
| G0378 | Hospital observation service, per hour | 1,014 | 900 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 107 | 97 | $2K |
| 93971 | 41 | 38 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 72 | 69 | $2K |
| 81025 | 1,369 | 1,230 | $2K | |
| 83690 | 2,670 | 2,328 | $1K | |
| 85027 | 1,154 | 1,060 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 280 | 256 | $1K |
| 84703 | 960 | 884 | $1K | |
| 83880 | 866 | 771 | $1K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 618 | 550 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,813 | 3,352 | $1K |
| 41899 | Unlisted procedure, dentoalveolar structures | 275 | 258 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | 128 | 124 | $961.80 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 670 | 640 | $920.55 |
| 87081 | 45 | 45 | $915.38 | |
| 82247 | 132 | 74 | $910.93 | |
| 80074 | 60 | 58 | $853.29 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,150 | 1,975 | $828.47 |
| 70486 | 12 | 12 | $804.96 | |
| 86592 | 27 | 27 | $757.03 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 515 | 486 | $656.62 |
| 85007 | 289 | 265 | $615.39 | |
| 87040 | 1,133 | 736 | $605.69 | |
| 86803 | 29 | 28 | $533.69 | |
| 86703 | 265 | 259 | $401.24 | |
| 83540 | 262 | 251 | $346.87 | |
| 82728 | 55 | 51 | $335.36 | |
| 83605 | 1,402 | 1,195 | $327.67 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 394 | 360 | $310.26 |
| 86900 | 481 | 423 | $260.61 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 157 | 145 | $237.75 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,288 | 1,161 | $221.82 |
| 84403 | 14 | 13 | $181.01 | |
| 82950 | 12 | 12 | $154.52 | |
| 73502 | 14 | 13 | $142.97 | |
| 82607 | 34 | 29 | $129.39 | |
| 87276 | 819 | 785 | $114.41 | |
| 85652 | 886 | 779 | $95.20 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 614 | 592 | $91.75 |
| 82550 | 148 | 127 | $83.87 | |
| 82150 | 119 | 111 | $68.33 | |
| 83735 | 912 | 755 | $62.35 | |
| 82565 | 52 | 44 | $60.92 | |
| 88304 | 75 | 51 | $51.05 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 33 | 16 | $47.77 |
| 85730 | 698 | 628 | $23.80 | |
| 87186 | 1,122 | 1,010 | $23.79 | |
| 86677 | 57 | 57 | $12.95 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 42 | 40 | $0.00 |
| 82977 | 44 | 41 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 47 | 40 | $0.00 |
| 87653 | 43 | 43 | $0.00 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 25 | 22 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 15 | 12 | $0.00 |
| 94761 | 92 | 84 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 1,954 | 1,774 | $0.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 183 | 143 | $0.00 |
| 86901 | 467 | 411 | $0.00 | |
| A9270 | Non-covered item or service | 246 | 235 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 85 | 81 | $0.00 |
| 83550 | 145 | 137 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 587 | 524 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 12 | 12 | $0.00 |
| 96376 | 419 | 362 | $0.00 | |
| 82746 | 16 | 14 | $0.00 | |
| 82553 | 45 | 40 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 33 | 31 | $0.00 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 13 | 12 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 45 | 41 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 15 | 14 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 12 | 12 | $0.00 |
| 97162 | 12 | 12 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 13 | 12 | $0.00 |